TDAQ offers a compelling 17.6% yield via daily call options on the NASDAQ-100. Read why I rate TDAQ a buy for income-focused ...

Invesco Income Fund Class A shares at net asset value had a positive absolute return for the quarter. Non-Agency RMBS, ABS ...

Azure growth 43% with 45% outlook, $678B RPO visibility, and AI chips cutting costs. Read here for a detailed analysis.

This is where we are now, but importantly, it leaves open the risk that we're at the beginning of an overshoot process that ...

Knife River rose after The Wall Street Journal said activist investor Starboard Value has built a significant stake and plans ...

This article provides two investment ideas with high yields that are currently very out of favor but are not expected to go ...

Gilead Sciences is rated Sell, with a $97.46 fair value versus the $150.56 closing price, implying 35.3% downside. Click for ...

Cava (CAVA) hits 500 restaurants, expands to 30 states, targets 1,000 by 2032, and new stores average $3M+ sales.

Everyday Options: For me, the best critical minerals play right now is Idaho Strategic Resources ( IDR ), because it is one ...

U.S. nonresidential construction starts rose as data-center projects surged, offsetting weaker infrastructure.

PFIX, RISR, SRLN & CLOZ—targeting 6–7% income and hedging inflation and rising rates. Click for more on these picks.

Labcorp dives on CMS 2027 Medicare lab-payment cuts; see why the selloff may be overdone, and the downside capped and why ...